Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar Vaidya

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
3 Biotech|April 13, 2017
Metabolism of pyrene through phthalic acid pathway by enriched bacterial consortium composed of Pseudomonas, Burkholderia, and Rhodococcus (PBR)Sagar Vaidya, Kunal Jain, Datta Madamwar
Frontiers in Microbiology|July 18, 2018
Degradation of Chrysene by Enriched Bacterial ConsortiumSagar Vaidya, Neelam Devpura, Kunal Jain, et al.
Immunity|October 2, 2002
IRF3 mediates a TLR3/TLR4-specific antiviral gene programSean Doyle, Sagar Vaidya, Ryan O'Connell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 27, 2022
First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia BPaul Harmatz, Carlos E Prada, Barbara K Burton, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
3 Biotech|April 13, 2017
Metabolism of pyrene through phthalic acid pathway by enriched bacterial consortium composed of Pseudomonas, Burkholderia, and Rhodococcus (PBR)Sagar Vaidya, Kunal Jain, Datta Madamwar
Frontiers in Microbiology|July 18, 2018
Degradation of Chrysene by Enriched Bacterial ConsortiumSagar Vaidya, Neelam Devpura, Kunal Jain, et al.
Immunity|October 2, 2002
IRF3 mediates a TLR3/TLR4-specific antiviral gene programSean Doyle, Sagar Vaidya, Ryan O'Connell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 27, 2022
First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia BPaul Harmatz, Carlos E Prada, Barbara K Burton, et al.
Pageof 1